Investing

OPKO Health : OPK

OPK

Stock Data

$1.34

$0.01 (0.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Opko Health Inc is a diverse healthcare company that operates globally, offering a mix of diagnostic and pharmaceutical services. It runs BioReference Laboratories, providing a wide range of laboratory testing services to detect and monitor diseases. Opko also develops and markets pharmaceuticals, including treatments for chronic kidney disease, secondary hyperparathyroidism, type 2 diabetes, and obesity. Additionally, it focuses on creating immune therapies for oncology and infectious diseases, alongside developing long-acting versions of approved therapeutic proteins. Founded in 1991, Opko is based in Miami, Florida, with operations in several countries.

All OPKO Health Articles

3 Articles

Trey Thoelcke | Aug 22, 2024 at 9:15 AM EDT

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024

With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for…

Trey Thoelcke | Jan 20, 2024 at 10:49 AM EST

More Big Warren Buffett Purchases Highlight Recent Insider Buying

Insider buying was somewhat slow in the middle of January, but some purchases by Warren Buffett's Berkshire Hathaway made headlines.

Trey Thoelcke | Jan 17, 2024 at 12:59 PM EST

New Year’s Insider Buying Focuses on Biotechs

As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on…